Ultiva
Drug
Mylan Specialty L.P.
Total Payments
$189,341
Transactions
1,172
Doctors
1,016
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $41,625 | 2 | 0 |
| 2017 | $147,716 | 1,170 | 1,016 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $111,000 | 3 | 58.6% |
| Consulting Fee | $41,800 | 3 | 22.1% |
| Food and Beverage | $17,025 | 1,137 | 9.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,867 | 11 | 6.8% |
| Travel and Lodging | $5,149 | 17 | 2.7% |
| Space rental or facility fees (teaching hospital only) | $1,500 | 1 | 0.8% |
Payments by Type
Research
$111,000
3 transactions
General
$78,341
1,169 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Subramaniam-The Effect of Intraoperative Continuous Remifentanil Infusion on Glycemic Response and Variability | Mylan Specialty L.P. | $69,375 | 0 |
| The Effect of Intraoperative Continuous Remifentanil Infusion on Glycemic Response and Variability | Mylan Specialty L.P. | $41,625 | 0 |
Top Doctors Receiving Payments for Ultiva — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Ronald Sakamoto | — | Bel Air, MD | $38.97 | 2 |
| , MD | Anesthesiology | Kansas City, MO | $36.83 | 2 |
| , M.D | Anesthesiology | Kansas City, MO | $36.83 | 2 |
| , DO | Pediatric Anesthesiology | Kansas City, MO | $36.83 | 2 |
| , MD | Anesthesiology | Baltimore, MD | $33.87 | 2 |
| , M.D | Anesthesiology | Rockville, MD | $33.87 | 2 |
| , M.D | Anesthesiology | Rockville, MD | $33.87 | 2 |
| , M.D | Anesthesiology | Rockville, MD | $33.87 | 2 |
| , MD | Specialist | Baltimore, MD | $33.87 | 2 |
| , M.D | Anesthesiology | Rockville, MD | $33.87 | 2 |
| , M.D | Pediatric Anesthesiology | Kansas City, MO | $33.29 | 2 |
| , M.D | Anesthesiology | Long Beach, CA | $33.20 | 2 |
| , M.D | Anesthesiology | Long Beach, CA | $33.20 | 2 |
| , M.D | Anesthesiology | Long Beach, CA | $33.20 | 2 |
| , M.D | Pediatric Anesthesiology | Long Beach, CA | $33.20 | 2 |
| , ANESTHESIOLOGIST | Specialist | Huntington, WV | $32.73 | 2 |
| , M.D | Anesthesiology | North Chesterfield, VA | $32.24 | 2 |
| , M.D | Anesthesiology | Torrance, CA | $31.05 | 2 |
| , MD | Anesthesiology | Torrance, CA | $31.05 | 2 |
| , M.D | Anesthesiology | Torrance, CA | $31.05 | 2 |
| , M.D | Anesthesiology | Torrance, CA | $31.05 | 2 |
| , M.D | Anesthesiology | Torrance, CA | $31.05 | 2 |
| , M.D | Anesthesiology | Torrance, CA | $31.05 | 2 |
| , M.D | Anesthesiology | Torrance, CA | $31.05 | 2 |
| , M.D | Anesthesiology | Parkersburg, WV | $30.65 | 2 |
Ad
Manufacturing Companies
- Mylan Specialty L.P. $187,841
- Mylan Pharmaceuticals Inc. $1,500
Product Information
- Type Drug
- Total Payments $189,341
- Total Doctors 1,016
- Transactions 1,172
About Ultiva
Ultiva is a drug associated with $189,341 in payments to 1,016 healthcare providers, recorded across 1,172 transactions in the CMS Open Payments database. The primary manufacturer is Mylan Specialty L.P..
Payment data is available from 2017 to 2018. In 2018, $41,625 was paid across 2 transactions to 0 doctors.
The most common payment nature for Ultiva is "Unspecified" ($111,000, 58.6% of total).
Ultiva is associated with 2 research studies, including "Subramaniam-The Effect of Intraoperative Continuous Remifentanil Infusion on Glycemic Response and Variability" ($69,375).